Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 3;3(8):e2015041.
doi: 10.1001/jamanetworkopen.2020.15041.

Association of Exposure to Endocrine-Disrupting Chemicals During Adolescence With Attention-Deficit/Hyperactivity Disorder-Related Behaviors

Affiliations

Association of Exposure to Endocrine-Disrupting Chemicals During Adolescence With Attention-Deficit/Hyperactivity Disorder-Related Behaviors

Jessica R Shoaff et al. JAMA Netw Open. .

Abstract

Importance: Attention-deficit/hyperactivity disorder (ADHD) is the most common childhood neurobehavioral disorder. Studies suggest that prenatal and early childhood exposure to endocrine-disrupting chemicals may be associated with ADHD, but the association during adolescence has not been studied to date.

Objective: To evaluate the association between exposure to select endocrine-disrupting chemicals during adolescence and ADHD-related behaviors.

Design, setting, and participants: For this cross-sectional analysis, data were collected from 205 adolescents in the New Bedford Cohort, an ongoing prospective birth cohort, between June 18, 2011, and June 10, 2014. The adolescents provided spot urine samples and underwent neurodevelopmental testing. Statistical analyses performed from January 15 to December 31, 2019, used a repeated-measures analysis with multivariate modified Poisson models to estimate the adjusted relative risk of ADHD-related behaviors associated with exposure to endocrine-disrupting chemicals.

Exposures: Urinary biomarker concentrations of endocrine-disrupting chemicals or their metabolites, including phthalates, parabens, phenols, and triclocarban, were quantified. Summary exposure measures were created, combining biomarker concentrations of chemicals with a shared mechanism of action, exposure pathway, or chemical class.

Main outcomes and measures: Behaviors related to ADHD were assessed with up to 14 indices from self-, parent-, and teacher-completed behavioral checklists using validated and standardized instruments; specifically, the Conners Attention Deficit Scale and the Behavior Assessment System for Children, Second Edition. Scores on each index were dichotomized to identify those with evidence of a significant behavioral problem, defined by each scale's interpretive guidelines.

Results: Among the 205 participants, the mean (SD) age at assessment was 15.3 (0.7) years, with 112 girls (55%) and 124 non-Hispanic White participants (61%). The median urine concentrations were 0.45 μmol/L of Σantiandrogenic phthalates, 0.13 μmol/L of ΣDEHP metabolites, 0.49 μmol/L of Σpersonal care product phthalates, 0.35 μmol/L of Σparabens, 0.02 μmol/L of Σbisphenols, and 0.02 μmol/L of Σdichlorophenols. A total of 82 (40%) had scores consistent with a significant behavioral problem, whereas 39 (19%) had an ADHD diagnosis. Each 2-fold increase in the sum of antiandrogenic phthalate concentrations was associated with a 1.34 (95% CI, 1.00-1.79) increase in the risk of significant ADHD-related behavior problems, whereas a 2-fold increase in the sum of dichlorophenols was associated with a 1.15 (95% CI, 1.01-1.32) increased risk. These associations tended to be stronger in male participants, but comparisons of sex-specific differences were imprecise.

Conclusions and relevance: Endocrine-disrupting chemicals are used in a wide variety of consumer products resulting in ubiquitous exposure. The study findings suggest that exposure to some of these chemicals, particularly certain phthalates, during adolescence may be associated with behaviors characteristic of ADHD.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Coull reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study, receiving grants from the US Environmental Protection Agency and the NIH, and working on the Apple Women’s Health Study outside the submitted work. Dr Korrick reported receiving grants from the NIH/National Institute of Environmental Health Sciences during the conduct of the study. No other disclosures were reported.

Figures

Figure.
Figure.. Adjusted Relative Risk of Multiple Measures of Clinically Significant Attention-Deficit/Hyperactivity Disorder (ADHD)–Associated Behaviors Corresponding to a 2-Fold Increase in Urinary Biomarker Concentrations in New Bedford Cohort Adolescents (Sample Size From 164 to 190)
Adjusted for child characteristics: sex, race/ethnicity, mean test age (across teacher-reported, parent-reported, and self-reported Behavior Assessment System for Children, 2nd Edition [BASC-2] and Conners Attention Deficit Scale [CADS] measures), and urine specific gravity; maternal characteristics at delivery: age, income, marital status, smoking, and educational level; and test indicator. The ADHD-associated behavior measures include CADS parent-reported and teacher-reported inattention, hyperactivity, and ADHD; BASC-2 parent-reported, teacher-reported, and self-reported hyperactivity and inattention; and BASC-2 parent-reported and teacher-reported executive function. Significant behavior problem: scale T-score dichotomized at the 98th percentile. aSum of mono-n-butyl phthalate (MBP), monoisobutyl phthalate (MiBP), monobenzyl phthalate, mono-2-ethylhexyl phthalate (MEHP), mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP), mono-2-ethyl-5-oxohexyl phthalate (MEOHP), mono-2-ethyl-5-carboxypentyl phthalate (MECPP), monocarboxyoctyl phthalate, monohydroxyisobutyl phthalate (MHiBP), monohydroxybutyl phthalate (MHBP), and mono-isononyl phthalate. bSum of MECPP, MEHHP, MEOHP, and MEHP. cSum of MBP, MHBP, monoethyl phthalate, MiBP, and MHiBP. dSum of butyl, ethyl, methyl, and propyl parabens. eSum of bisphenol A, bisphenol F, and bisphenol S. fSum of 2,4-dichlorophenol and 2,5-dichlorophenol.

Similar articles

Cited by

References

    1. Danielson ML, Bitsko RH, Ghandour RM, Holbrook JR, Kogan MD, Blumberg SJ. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. J Clin Child Adolesc Psychol. 2018;47(2):199-212. doi:10.1080/15374416.2017.1417860 - DOI - PMC - PubMed
    1. Abright AR. Estimating the costs of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2012;51(10):987-989. doi:10.1016/j.jaac.2012.07.012 - DOI - PubMed
    1. Froehlich TE, Lanphear BP, Auinger P, et al. . Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics. 2009;124(6):e1054-e1063. doi:10.1542/peds.2009-0738 - DOI - PMC - PubMed
    1. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161(9):857-864. doi:10.1001/archpedi.161.9.857 - DOI - PubMed
    1. Tewar S, Auinger P, Braun JM, et al. . Association of bisphenol A exposure and attention-deficit/hyperactivity disorder in a national sample of U.S. children. Environ Res. 2016;150:112-118. doi:10.1016/j.envres.2016.05.040 - DOI - PubMed

Publication types